Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI

Area of Science:

• Neurology
• Nuclear Medicine
• Radiology

Background:

• Diagnosing rare movement disorders, such as Huntington's disease (HD), presents challenges, particularly in sporadic cases lacking family history.
• Standard MRI in HD patients often shows striatal atrophy and white matter volume reduction, but these findings can be nonspecific.
• Functional imaging techniques like Positron Emission Tomography (PET) can offer crucial diagnostic information when morphological MRI results are unclear.

Observation:

• A case report details a 56-year-old woman presenting with mild hypokinetic-rigid syndrome and depression.
• The patient's symptoms were initially suspicious of Parkinson's disease.
• The patient underwent 18F-DOPA and 18F-FDG PET/MRI scans for further diagnostic evaluation.

Findings:

• While the abstract does not detail the specific findings of the PET/MRI scans, it highlights their utility in cases with unspecific morphological findings.
• The use of 18F-DOPA PET/MRI can assess dopaminergic function, aiding in the differential diagnosis of movement disorders.
• 18F-FDG PET/MRI can evaluate regional glucose metabolism, providing complementary information.

Implications:

• Functional PET/MRI imaging can significantly aid in the differential diagnosis of rare movement disorders when clinical presentation and standard MRI are ambiguous.
• This case underscores the importance of advanced imaging techniques in diagnosing conditions like Huntington's disease, especially in atypical presentations.
• Integrating PET tracers like 18F-DOPA and 18F-FDG with MRI enhances diagnostic accuracy for complex neurological cases.